Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1179099.RAHIfdUaQm0PStWbXR-g0DR4KFdlEzW99--cE9Z5CX1i4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1179099.RAHIfdUaQm0PStWbXR-g0DR4KFdlEzW99--cE9Z5CX1i4130_assertion type Assertion NP1179099.RAHIfdUaQm0PStWbXR-g0DR4KFdlEzW99--cE9Z5CX1i4130_head.
- NP1179099.RAHIfdUaQm0PStWbXR-g0DR4KFdlEzW99--cE9Z5CX1i4130_assertion description "[A significant increase in total cholesterol, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol (LDL-C), apolipoprotein B (ApoB), and lipoprotein (a) (Lp(a)) and a significant decrease in apolipoprotein A1 (ApoA1), ApoA1/ApoB ratio, and PON1 activity/HDL-C ratio were observed in children with T1D compared with controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1179099.RAHIfdUaQm0PStWbXR-g0DR4KFdlEzW99--cE9Z5CX1i4130_provenance.
- NP1179099.RAHIfdUaQm0PStWbXR-g0DR4KFdlEzW99--cE9Z5CX1i4130_assertion evidence source_evidence_literature NP1179099.RAHIfdUaQm0PStWbXR-g0DR4KFdlEzW99--cE9Z5CX1i4130_provenance.
- NP1179099.RAHIfdUaQm0PStWbXR-g0DR4KFdlEzW99--cE9Z5CX1i4130_assertion SIO_000772 24793345 NP1179099.RAHIfdUaQm0PStWbXR-g0DR4KFdlEzW99--cE9Z5CX1i4130_provenance.
- NP1179099.RAHIfdUaQm0PStWbXR-g0DR4KFdlEzW99--cE9Z5CX1i4130_assertion wasDerivedFrom befree-2016 NP1179099.RAHIfdUaQm0PStWbXR-g0DR4KFdlEzW99--cE9Z5CX1i4130_provenance.
- NP1179099.RAHIfdUaQm0PStWbXR-g0DR4KFdlEzW99--cE9Z5CX1i4130_assertion wasGeneratedBy ECO_0000203 NP1179099.RAHIfdUaQm0PStWbXR-g0DR4KFdlEzW99--cE9Z5CX1i4130_provenance.